iShares Biotechnology ETF
IBB
NASDAQ
| Weiss Ratings | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Valuation | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $200.02 | |||
| Company Info | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | iShares | |||
| Manager/Tenure (Years) | Jennifer Hsui (14), Peter Sietsema (1), Matt Waldron (1), 1 other | |||
| Website | http://www.ishares.com | |||
| Phone Number | 415-670-2000 | |||
| Fund Information | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | iShares Biotechnology ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Technology | |||
| Inception Date | Feb 05, 2001 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.16% | |||
| Dividend | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.44% | |||
| Asset Allocation | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.13% | |||
| Stock | 99.86% | |||
| U.S. Stock | 94.69% | |||
| Non-U.S. Stock | 5.17% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.57% | |||
| 30-Day Total Return | -6.45% | |||
| 60-Day Total Return | 7.51% | |||
| 90-Day Total Return | 2.14% | |||
| Year to Date Total Return | 18.58% | |||
| 1-Year Total Return | 32.73% | |||
| 2-Year Total Return | 40.72% | |||
| 3-Year Total Return | 68.81% | |||
| 5-Year Total Return | 27.41% | |||
| Price | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $205.29 | |||
| 1-Month Low Price | $202.00 | |||
| 1-Month High Price | $213.81 | |||
| 52-Week Low Price | $149.95 | |||
| 52-Week Low Price (Date) | Oct 10, 2025 | |||
| 52-Week High Price | $216.96 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| NAV | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $202.07 | |||
| 1-Month High NAV | $213.85 | |||
| 52-Week Low NAV | $149.97 | |||
| 52-Week Low NAV (Date) | Oct 10, 2025 | |||
| 52-Week High NAV | $216.92 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| Beta / Standard Deviation | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.64 | |||
| Standard Deviation | 18.53 | |||
| Balance Sheet | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 11.20B | |||
| Operating Ratios | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.44% | |||
| Turnover Ratio | 27.00% | |||
| Performance | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 38.59% | |||
| Last Bear Market Total Return | -9.59% | |||